Background: Hypertrophic pulmonary osteoarthropathy (HPOA) secondary to bronchogenic carcinoma can be associated with severe, disabling pain which is not always responsive to conventional treatment.
Aim: To report on the use of pamidronate to control resistant pain in HPOA in three cases.
Methods: A retrospective review of reported pain, chest X-ray and radionuclide bone scans was made.
Results: Pain relief was achieved in all three cases together with reduced radiolabel uptake in two cases.
Conclusions: Pamidronate appears to be an effective therapy for HPOA. Further investigation is warranted.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1445-5994.1997.tb01983.x | DOI Listing |
Publication Analysis
Top Keywords
hypertrophic pulmonary
8
pulmonary osteoarthropathy
8
osteoarthropathy hpoa
8
pamidronate hypertrophic
4
hpoa
4
hpoa background
4
background hypertrophic
4
hpoa secondary
4
secondary bronchogenic
4
bronchogenic carcinoma
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!